• A Message From the CEO

    Accomplishing Things That Matter

    Dear Colleagues and Friends,

    As you peruse this Annual Report, I think you’ll be struck by a number of things. One of them, perhaps the most important, is that the Foundation accomplishes things that matter! It’s not just one or two programs, but a spectrum from professional education, to public education, to public service, to best-in-the world quality of care research. And the impact is sustained.

    More recently, the Foundation was essential to the development of the IRIS Clinical Data Registry. It required an investment of over $10 million. And it demanded of both the Academy and of the Foundation Board of Trustees a sense of vision and of commitment to build an infrastructure and the analytic technology necessary to succeed. The result is a transformative tool with impacts on federal policy, population-based research, quality of care and professional analytics.

    Next year we will witness the opening of the world’s only comprehensive, publicly-accessible Museum of the Eye. The lion’s share of the funding comes from our colleagues and Academy members—most notably, Drs. Stan Truhlsen and Mike Marmor. It’s a reflection of our own professional commitment to our heritage and to public education.

    Finally, as you read this report, note the generosity of your friends and colleagues. Please thank them on behalf of us all.

    Best regards,

     

    David W. Parke II, MD
    Chief Executive Officer
    American Academy of Ophthalmology

     

    The American Academy of Ophthalmology Foundation Advisory Board

    The American Academy of Ophthalmology Foundation

    The American Academy of Ophthalmology Foundation leadership is proud to support the Academy’s educational, quality of care and service programs. Through their generosity and guidance, these dedicated leaders drive our important work to advance eye health worldwide.

    Gregory L. Skuta, MD
    Chair
    President and CEO, Dean McGee Eye Institute
    Oklahoma City, Okla.

    Tony McClellan
    President
    Chairman, Brookend Enterprises Management Services, Ltd.
    Herefordshire, United Kingdom

    F. Michael Ball
    Chairman-designate, Alcon, Inc.

    Fort Worth, Texas

    George B. Bartley, MD
    CEO, American Board of Ophthalmology
    Rochester, Minn.

    Thomas W. Burns
    President and CEO, Glaukos Corp.
    San Clemente, Calif.

    Thomas G. Frinzi
    Worldwide President, Surgical, Johnson & Johnson Vision
    Santa Ana, Calif.

    David D. Goodwin
    Trustee, Knights Templar Eye Foundation, Inc.
    Vestal, N.Y.

    H. Dunbar Hoskins Jr., MD
    Executive Vice President Emeritus
    American Academy of Ophthalmology
    Belvedere, Calif.

    James V. Mazzo
    Global President, Ophthalmic Devices,
    Carl Zeiss Meditec, Inc.
    Dublin, Calif.

    Christie L. Morse, MD
    Ophthalmologist, Concord Eye Care
    Concord, N.H.

    Charles R. Munnerlyn, PhD
    Co-founder and Retired CEO, VISX, Inc.
    San Jose, Calif.

    David E. I. Pyott, CBE, MD (Hon.)
    Former Chairman and CEO, Allergan, Inc.
    Irvine, Calif.

    Brent L. Saunders
    CEO and President, Allergan plc
    Madison, N.J.

    Peter J. Whitted, MD, JD
    Ophthalmologist, Midwest Eye Care
    Omaha, Neb.

    - - - - - - - - - - 

    David W. Parke II, MD
    CEO
    American Academy of Ophthalmology
    San Francisco, Calif.

    Tina McGovern
    Executive Director
    American Academy of Ophthalmology Foundation
    San Francisco, Calif.